Trials / Unknown
UnknownNCT06108401
Effect Of a Goat Milk-Based Infant Formula On Gastrointestinal And Other Symptoms And Health-Related Quality Of Life.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (estimated)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 14 Days – 90 Days
- Healthy volunteers
- Accepted
Summary
In this trial, the investigators aim to assess impact of goat milk-based infant formula on the severity and frequency of gastrointestinal symptoms, as well as other associated symptoms, and the health-related quality of life in infants exhibiting symptoms possibly related to cow's milk, compared to a cow milk-based formula.
Detailed description
Gastrointestinal symptoms are frequent in the first 6 months of life in otherwise healthy infants fed cow milk-based infant formulas (CMF). In management special infant formulas may be considered, although none is routinely recommended. Goat milk-based infant formulas (GMF) have shown promising effects on digestion and increased gastric emptying in several in vitro studies. In this trial, a total of 158 participants at age 14 to 90 days, who exhibit gastrointestinal and/or other symptoms associated with CMF consumption, as assessed with the Cow's Milk-related Symptom Score (CoMiSS) between 6 and 10 will be randomly allocated to GMF or CMF for four weeks. The primary outcome will be the proportion of infants showing a reduction of at least 4 points in CoMiSS following the four-week intervention period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Goat milk-based infant formula | Goat milk-based infant formula exclusively for 4 weeks at a volume depending on the infant. |
| DIETARY_SUPPLEMENT | Cow milk-based infant formula | Regular cow milk-based infant formula that is similar in color, smell, and taste to the formula received by the experimental group. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-10-31
- Last updated
- 2023-10-31
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06108401. Inclusion in this directory is not an endorsement.